forecasted

Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)

Opportunity Number: FOR-TR-27-002CFDA Numbers: 93.350
Posted: Closed on Jun 27, 2025

Stay Updated

Get notified about new opportunities matching your interests.